Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 6Completed 3Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 3Stomach Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Neoplasm Metastasis 1HIPEC 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 6Paclitaxel 5Carboplatin 4Bevacizumab 3oregovomab 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2Cisplatin 2tislelizumab 1spartalizumab 1rucaparib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1fludarabine 1denileukin diftitox 1anlotinib 1Surveys and Questionnaires 1Saline Solution 1Ramucirumab 1Platinum 1Nutrition Assessment 1Neoadjuvant Therapy 1Leucovorin 1Irinotecan 1Immunotherapy, Adoptive 1Glucose 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Ovarian Epithelial × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT05316181 2026-02-12

KOV-HIPEC-02R

National Cancer Center, Korea

Phase 3 Active not recruiting
140 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02124421 2024-11-19

CRS/HIPEC

Mercy Medical Center

Phase 2 Active not recruiting
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡